PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
PPP2CB |
PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
3.777 |
Evidence |
O
|
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.777 |
Evidence |
|
PRKAA2 |
PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 |
CRKRS |
CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 |
3.777 |
Evidence |
|
USP7 |
USP7, HAUSP: Ubiquitin carboxyl-terminal hydrolase 7 |
HIPK3 |
HIPK3, DYRK6, FIST3, PKY: Homeodomain-interacting protein kinase 3 |
3.777 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
3.777 |
Evidence |
|
PPP2CB |
PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
3.777 |
Evidence |
|
BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
3.777 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
3.77 |
Evidence |
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
PLD1 |
PLD1: Phospholipase D1 |
3.77 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
3.77 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
PTPN11 |
IPI00298347 |
3.77 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
3.77 |
Evidence |
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
CCT8 |
CCT8: Uncharacterized protein CCT8 |
3.77 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
IEF-SSP-9502 |
PWP1: Periodic tryptophan protein 1 homolog |
3.77 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
CRK |
IPI00399054 |
3.77 |
Evidence |
O
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
3.77 |
Evidence |
|
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
TIMELESS |
TIMELESS, TIM, TIM1, TIMELESS1: Protein timeless homolog |
3.77 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
3.77 |
Evidence |
|
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
3.77 |
Evidence |
|
VIL1 |
VIL1, VIL: Villin-1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
3.77 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
GMFB |
GMFB: Glia maturation factor beta |
3.77 |
Evidence |
|
NCAM2 |
NCAM2, NCAM21: Neural cell adhesion molecule 2 precursor |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.77 |
Evidence |
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
CCT2 |
CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta |
3.77 |
Evidence |
|
PRKG1 |
PRKG1, PRKG1B, PRKGR1B: cGMP-dependent protein kinase 1, beta isozyme |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
3.77 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
3.77 |
Evidence |
|